Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination

KEY CLINICAL MESSAGE: Alopecia areata may develop in patients after COVID‐19 vaccination. Platelet‐rich plasma (PRP) has an outstanding anti‐inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids. ABSTRACT: A 34‐year‐old fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Hsiang‐Chiun, Chen, Hsin‐Hsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182003/
https://www.ncbi.nlm.nih.gov/pubmed/37192849
http://dx.doi.org/10.1002/ccr3.7342
Descripción
Sumario:KEY CLINICAL MESSAGE: Alopecia areata may develop in patients after COVID‐19 vaccination. Platelet‐rich plasma (PRP) has an outstanding anti‐inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids. ABSTRACT: A 34‐year‐old female with no systemic illness presented with non‐scarring hair loss after the second COVID‐19 vaccination shot 4 weeks ago. The hair loss worsened and progressed to severe alopecia areata. We started double‐spin PRP therapy. Her hair recovered completely after six courses of PRP treatment.

Ejemplares similares